Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3969 results

Sort By:

Study Comparing Two Administration Pathways for Adenosine During Microvascular Function Assessment

Study ID: NCT06269874
Start Date: 2027-03-02
End Date: 2027-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

microvascular function assessment

Sponsor

Johannes Gutenberg University Mainz

Source: clinicaltrials.gov

Share:
Add to list

Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem

Study ID: NCT05106127
Start Date: 2025-08
End Date: 2026-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

28

Intervention / Treatment

EG-007

Pembrolizumab 100 mg/4 mL (25 mg/ml) Injection

Lenvatinib Capsules

Sponsor

Evergreen Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing Blindness

Study ID: NCT06023927
Start Date: 2025-09-02
End Date: 2028-09-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Clinical observation, diagnostic testing

Sponsor

Northwell Health

Source: clinicaltrials.gov

Share:
Add to list

Atropine Eyedrops for Myopia Progression in Children and Adolescents (MODERATO STUDY)

Study ID: NCT07028827
Start Date: 2025-07-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

234

Intervention / Treatment

0.05% atropine eye drops

0.025% atropine eye drops

placebo eye drops

Sponsor

Ocus Innovation Ireland Limited

Source: clinicaltrials.gov

Share:
Add to list

Topical Vancomycin for Infection Prophylaxis in TJA

Study ID: NCT04993027
Start Date: 2025-12-30
End Date: 2028-12-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Vancomycin Powder

Sponsor

Alberta Hip and Knee Clinic

Source: clinicaltrials.gov

Share:
Add to list

Comparison of Two Over the Counter Intravaginal Devices for the Treatment of Stress Urinary Incontinence

Study ID: NCT06698627
Start Date: 2025-09-01
End Date: 2028-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Daily Disposable Continence Device

Monthly Disposable Continence Device

Sponsor

Vanderbilt University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.

Study ID: NCT05776927
Start Date: 2026-02-01
End Date: 2029-02-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

304

Intervention / Treatment

QVM149

Salmeterol Xinafoate / Fluticasone Propionate

Placebo to QVM149

Placebo to Salmeterol Xinafoate / Fluticasone Propionate

Run-In Medication

Rescue Medication

Concept 1 Device

Girohaler

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Dissecting the Roles of High-quality Diets and Ultra Processed Foods on Cardiometabolic Health

Study ID: NCT06749327
Start Date: 2025-10-01
End Date: 2029-03-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

330

Intervention / Treatment

High UPF, high hPDI diet

Low UPF, high hPDI diet

Sponsor

Queen's University, Belfast

Source: clinicaltrials.gov

Share:
Add to list

Inclined Versus Standard Exercise for COPD Patients

Study ID: NCT06749262
Start Date: 2025-12-01
End Date: 2029-10-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

54

Intervention / Treatment

walking on incline or walking at increasing speed for 36 visits

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex

Study ID: NCT06924827
Start Date: 2025-07-02
End Date: 2027-08
Study Type

Interventional

Study Phase

Phase4

No. of Participants

25

Intervention / Treatment

Epidiolex 100 mg/mL Oral Solution

Sponsor

Elizabeth Donner

Source: clinicaltrials.gov

Share:
Add to list